Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 14, 2021; 27(38): 6348-6356
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6348
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6348
Figure 1 Thiopurine metabolic pathway and possible biomarkers for drug-related toxicity.
Dashed arrows indicate the impact of PACSIN2 on TPMT activity and the interaction between PACSIN2 and Rac-1. AZA: Azathioprine; ITPA: Inosine triphosphate pyrophosphatase; IMPDH: Inosine-5′-monophosphate dehydrogenase; GMPS: GMP synthase; GST: Glutathione-S-transferase; Me-TIMP: Methyl-thioinosine monophosphate; Me-TITP: Methyl-thioinosinetriphosphate; MP: Mercaptopurine; MMP: Methyl-mercaptopurine; NUDT15: Nudix hydrolase 15; PACSIN2: Protein kinase C and casein kinase substrate in neurons protein 2; TGDP: Thioguanine diphosphate; TGMP: Thioguanine monophosphate; TGTP: Thioguanine triphosphate; TIMP: Thioinosine monophosphate; TITP: Thioinosine triphosphate; TNG: 6-Thioguanine nucleotide; TPMT: Thiopurine S-methyltransferase; TXMP: Thioxanthine monophosphate; 6-TU acid: Thiouric acid; XO: Xanthine oxidase.
- Citation: Zudeh G, Franca R, Stocco G, Decorti G. Biomarkers for gastrointestinal adverse events related to thiopurine therapy. World J Gastroenterol 2021; 27(38): 6348-6356
- URL: https://www.wjgnet.com/1007-9327/full/v27/i38/6348.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i38.6348